Virpax Pharmaceuticals (VRPX) Pharmaceuticals Updates on Litigation

Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) today announced that it has received a ruling on the lawsuit filed by Scilex Pharmaceuticals (NASDAQ: SCLX) and Sorrento Therapeutics, the now bankrupt majority owner of Scilex Pharmaceuticals.

The Court found in favor of the plaintiffs (on all but three counts deemed to have been waived). However, no damages judgment was specified in the ruling which called for additional proceedings to determine the remedy.

You May Also Be Interested In

• Morgan Stanley Private Credit Fund Caps Redemptions At 5%
• BNY Mellon fund boards retain seats after defeating dissident nominee
• Eldorado Gold elects nine directors at 2026 annual meeting